EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, AMLX: Amylyx Pharmaceuticals Inc

28 Nov 25 13:01
LAST:

14.98

CHANGE:
 0.02		OPEN:
15.12		HIGH:
15.24		ASK:
0.00		VOLUME:
314.3K
CHG(%):
0.13		PREV:
15.00		LOW:
14.70		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
28 Nov 2515.1215.2414.7014.98421.4K
26 Nov 2514.8615.1414.6715.00955.6K
25 Nov 2514.7515.2114.4814.88896.1K
24 Nov 2514.8715.3914.6514.823.19M
21 Nov 2513.4214.8413.0814.671.3M
20 Nov 2514.5614.9413.5213.571.03M
19 Nov 2513.9715.0913.9014.321.48M
18 Nov 2513.8514.1213.4113.951.29M
17 Nov 2512.7114.3412.6113.982.17M
14 Nov 2512.3812.8012.1512.691.56M

PROFILE

Name:Amylyx Pharmaceuticals Inc
About:Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. Its lead products candidate includes avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:43 Thorndike Street, Cambridge, MA, United States, 02141
Website:https://amylyx.com
CUSIP:032108508
CIK:0001658551
ISIN:US0321085088
FIGI:BBG00DP10YT5
LEI:549300N7RNU56EKK7U80

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:2.54 
Forward P/E:-7.53 
PEG Ratio:-0.04 
Price to Sales:-5,967.38 
Price to Book:7.40 
Profit Margin:-0.43 
Operating Margin:791.06 
Return on Assets:-0.47 
Return on Equity:-0.87 
EPS Ratio:-2.49 
Revenue:-249,000 
Shares:106.67M 
Market Cap:1.598B 

TECHNICAL INDICATORS

MA5:14.870.7%
MA10:14.294.9%
MA20:13.5910.2%
MA50:13.937.6%
MA100:11.4830.5%
MA200:8.0386.6%
STO9:77.47
STO14:87.23 
RSI14:75.53 
WPR14:-0.71 
MTM14:2.80
ROC14:0.23 
ATR:0.94 
Week High:15.392.7%
Week Low:13.0814.5%
Month High:15.392.7%
Month Low:11.7986.6%
Year High:16.9613.2%
Year Low:2.60476.2%